Levosimendan Efficacy for Veno-arterial ECMO Weaning: a Retrospective Study (LEVO-ECMO)

University Hospital, Strasbourg, France

Status: Unknown

Conditions: Cardiogenic Shock

Study type: Observational

Funder types: Other

Identifiers

NCT03346824

6946

Details and patient eligibility

About

Failure of Weaning from ECMO is a serious complication, reaching an incidence between 29 and 58%. Inotrops are frequently used to help separating patient from ECMO. Levosimendan is an ino-dilatatory medication and was used in different clinical settings. The aim of this study was to evaluate the benefit with levosimendan when used in weaning process.

Enrollment: 65 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age over 18
• Patient requiring the need for short-term assistance
• Patient who has agreed to use his medical data for research purposes

Exclusion criteria

• Refusal to participate in the study
• Non-weaning attempts due to a death under assistance or a relay by a long-term assistance or heart transplant
• Non-cardiac indications of assistance (indication of pulmonary replacement)
• Subject under guardianship or curatorship